BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37222685)

  • 21. Higher lymph node harvest in patients with a pathologic complete response after neoadjuvant therapy for esophageal cancer is associated with improved survival.
    Lutfi W; Martinez-Meehan D; Dhupar R; Christie N; Sarkaria I; Ekeke C; Baker N; Luketich JD; Okusanya OT
    J Surg Oncol; 2020 Mar; 121(4):654-661. PubMed ID: 31970776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of different lymph node staging methods in esophageal squamous cell carcinoma after esophagectomy.
    Wu SG; Li FY; Zhou J; Lin Q; Sun JY; Lin HX; Guan XX; He ZY
    Ann Thorac Surg; 2015 Jan; 99(1):284-90. PubMed ID: 25440270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of Metastatic Status and Number of Removed Lymph Nodes on Survival of Patients With Squamous Esophageal Carcinoma.
    Yuan F; Qingfeng Z; Jia W; Chao L; Shi Y; Yuzhao W; Chao A; Yue Y
    Medicine (Baltimore); 2015 Dec; 94(48):e1973. PubMed ID: 26632887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Number of Harvested LNs Is an Independent Prognostic Factor in Lymph Node Metastasis-negative Patients Who Received Curative Esophagectomy.
    Aoyama T; Atsumi Y; Kawahara S; Tamagawa H; Tamagawa A; Maezawa Y; Kano K; Murakawa M; Kazama K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
    In Vivo; 2020; 34(4):2021-2027. PubMed ID: 32606176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features of metastasis from superficial squamous cell carcinoma of the thoracic esophagus.
    Miyata H; Sugimura K; Motoori M; Omori T; Yamamoto K; Yanagimoto Y; Shinno N; Yasui M; Takahashi H; Wada H; Ohue M; Yano M
    Surgery; 2019 Dec; 166(6):1033-1040. PubMed ID: 31493901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of two‑field or three‑field lymphadenectomy on overall survival in middle and lower thoracic esophageal squamous cell carcinoma: A single‑center retrospective analysis.
    Li K; Du K; Liu K; Nie X; Li C; He W; Li K; Wang C; Li Z; Zheng K; Mao T; Jiang L; Li H; Miao Y; Xie Q; Fang Q; Han Y; Leng X; Peng L
    Oncol Lett; 2023 May; 25(5):189. PubMed ID: 37065785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcome of transthoracic esophagectomy with thoracic duct resection: Number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct.
    Matsuda S; Takeuchi H; Kawakubo H; Shimada A; Fukuda K; Nakamura R; Takahashi T; Wada N; Kameyama K; Kitagawa Y
    Medicine (Baltimore); 2016 Jun; 95(24):e3839. PubMed ID: 27310961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thoracic Duct Resection During Esophagectomy Does Not Contribute to Improved Prognosis in Esophageal Squamous Cell Carcinoma: A Propensity Score Matched-Cohort Study.
    Oshikiri T; Takiguchi G; Miura S; Goto H; Otsubo D; Hasegawa H; Yamamoto M; Kanaji S; Yamashita K; Matsuda T; Fujino Y; Tominaga M; Nakamura T; Suzuki S; Kakeji Y
    Ann Surg Oncol; 2019 Nov; 26(12):4053-4061. PubMed ID: 31313045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended Lymphadenectomy Improves Survival After Induction Chemoradiation for Esophageal Cancer: A Propensity-Matched Analysis of the National Cancer Database.
    Kamel MK; Harrison S; Lee B; Port JL; Stiles BM; Altorki NK
    Ann Surg; 2023 Apr; 277(4):e772-e776. PubMed ID: 34475320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic Cervical Lymph Node Dissection in Thoracoscopic Esophagectomy for Esophageal Cancer Increases Postoperative Complications and Does Not Improve Survival.
    Koterazawa Y; Oshikiri T; Takiguchi G; Hasegawa H; Yamamoto M; Kanaji S; Yamashita K; Matsuda T; Nakamura T; Fujino Y; Tominaga M; Suzuki S; Kakeji Y
    Ann Surg Oncol; 2019 Sep; 26(9):2899-2904. PubMed ID: 31187365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimally invasive oesophagectomy with extended lymph node dissection and thoracic duct resection for early-stage oesophageal squamous cell carcinoma.
    Matsuda S; Kawakubo H; Takeuchi H; Hayashi M; Mayanagi S; Takemura R; Irino T; Fukuda K; Nakamura R; Wada N; Kitagawa Y
    Br J Surg; 2020 May; 107(6):705-711. PubMed ID: 32077101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy comparison between two-field and three-field lymphadenectomy for thoracic esophageal squamous cell carcinoma].
    Lin D; Ye T; Ma L; Shao L; Song Z; Jiang S; Xiang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):990-994. PubMed ID: 27680065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of examined lymph node count for oesophageal squamous cell carcinoma in patients who underwent left transthoracic oesophagectomy.
    Zheng YZ; Li XQ; Wang JY; Yang H; Wen J; Zhai WY; Yuan LX; Fu SS; Liao HY; Fu JH
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1956-1962. PubMed ID: 32439262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics and clinical significance of recurrent laryngeal nerve lymph node metastasis in esophageal squamous cell carcinoma.
    Ma L; Xiang J; Zhang Y; Hu H; Shao R; Lin D
    J BUON; 2017; 22(6):1533-1539. PubMed ID: 29332349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic value of lymph node dissection for esophageal squamous cell carcinoma after neoadjuvant chemotherapy.
    Miyata H; Yamasaki M; Makino T; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
    J Surg Oncol; 2015 Jul; 112(1):60-5. PubMed ID: 26179950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Impact of Metastatic Lymph Node Size on Therapeutic Effect and Prognosis in Patients with Esophageal Squamous Cell Carcinoma Who Underwent Preoperative Chemotherapy Followed by Esophagectomy.
    Sugimura K; Miyata H; Kanemura T; Takeoka T; Sugase T; Yamamoto M; Shinnno N; Hara H; Omori T; Motoori M; Ohue M; Yano M
    Ann Surg Oncol; 2023 Jul; 30(7):4193-4202. PubMed ID: 37010661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of pathologically assessing extranodal extension in the thoracic field on the prognosis of esophageal squamous cell carcinoma.
    Okada N; Daiko H; Kanamori J; Sato A; Horikiri Y; Sato T; Fujiwara H; Tomioka T; Fujita T; Kojima T; Fujii S
    Surgery; 2019 Jun; 165(6):1203-1210. PubMed ID: 30850155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Numeric pathologic lymph node classification shows prognostic superiority to topographic pN classification in esophageal squamous cell carcinoma.
    Sugawara K; Yamashita H; Uemura Y; Mitsui T; Yagi K; Nishida M; Aikou S; Mori K; Nomura S; Seto Y
    Surgery; 2017 Oct; 162(4):846-856. PubMed ID: 28739092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic importance of pathologically involved celiac node metastases in node-positive patients with carcinoma of the distal esophagus or gastroesophageal junction: a surgical series from the Mayo Clinic.
    Schomas DA; Quevedo JF; Donahue JM; Nichols FC; Romero Y; Miller RC
    Dis Esophagus; 2010 Apr; 23(3):232-9. PubMed ID: 19515184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma.
    Jang HJ; Lee HS; Kim MS; Lee JM; Zo JI
    Ann Thorac Surg; 2011 Sep; 92(3):1091-7. PubMed ID: 21704967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.